Home/Filings/4/0001437749-23-015516
4//SEC Filing

McClung David 4

Accession 0001437749-23-015516

CIK 0000925741other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 9:31 PM ET

Size

7.1 KB

Accession

0001437749-23-015516

Insider Transaction Report

Form 4
Period: 2023-05-18
BioCardia, Inc.BCDA;BCDAW
McClung David
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2023-05-18$1.70/sh+61,389$104,361152,120 total
  • Award

    Stock Option (right to buy)

    2023-05-18+68,26568,265 total
    Exercise: $1.70Exp: 2033-05-18Common Stock (68,265 underlying)
Footnotes (2)
  • [F1]The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on May 18, 2023.
  • [F2]The option vests and becomes exercisable as to 1/48th of the shares on June 18, 2023, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.

Issuer

BioCardia, Inc.

CIK 0000925741

Entity typeother

Related Parties

1
  • filerCIK 0001686155

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 9:31 PM ET
Size
7.1 KB